Clinical trials of investigational new drugs for nonalcoholic steatohepatitis: challenges in design and practice
Research and development of investigational new drugs for nonalcoholic fatty liver disease is now a research hotspot in the field of liver disease. However, there are still great challenges in protocol design and implementation in phase II/III clinical trials. Since there are still controversies ove...
Main Author: | MAO Yimin |
---|---|
Format: | Article |
Language: | zho |
Published: |
Editorial Department of Journal of Clinical Hepatology
2017-12-01
|
Series: | Linchuang Gandanbing Zazhi |
Subjects: | |
Online Access: | http://www.lcgdbzz.org/qk_content.asp?id=8613 |
Similar Items
-
Drug discovery and treatment paradigms in nonalcoholic steatohepatitis
by: Mazen Noureddin, et al.
Published: (2020-10-01) -
Pharmacologic therapy for nonalcoholic steatohepatitis focusing on pathophysiology
by: In Cheol Yoon, et al.
Published: (2019-05-01) -
Genistein can ameliorate hepatic inflammatory reaction in nonalcoholic steatohepatitis rats
by: Yimin Yin, et al.
Published: (2019-03-01) -
Recent update: Nonalcoholic steatohepatitis
by: Vivek Hande, et al.
Published: (2018-01-01) -
Recent research trends and updates on nonalcoholic fatty liver disease
by: Jeong-Ju Yoo, et al.
Published: (2019-03-01)